Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed
Summary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
Summary : A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences…
Summary : Spain’s Rovi (ROVI.MC) has agreed a 10-year extension to its deal with Moderna (MRNA.O) to manufacture future drugs developed with…
Summary : Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy’s Laboratories to acquire two brands — Combihale and Daffy. While Combihale…
Summary : Glenmark Pharmaceuticals on Monday said its subsidiary has inked a pact to commercialise AstraZeneca’s asthma drug Pulmicort Respules in the…
Summary: Zydus, being one of the first applicants for Roflumilast Tablets, 500 mcg, is eligible for 180 days of shared generic drug…
Summary : The Rs 6,480-crore IPO of Gland Pharma, which was launched in November 2020, holds the record for the biggest ever…
Synopsis: For at least six months after COVID-19 vaccination, antibodies produced by immune cells become steadily more formidable and more precisely targeted…
Summary : Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes National Institute for Health…
Summary : SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy Around 55,000 people in…
Synopsis : Rare viral haemorrhagic disease similar to Ebola surface in the East of England. Two people in the UK have been…